Oxalate crystal deposition disease

Area of Science:

• Nephrology
• Rheumatology
• Genetics

Background:

• Oxalate crystals, though less common than other types, can deposit in joints causing arthritis.
• Oxalate crystal deposition disease (OCDD) is linked to primary hyperoxalurias (PH1 and PH2) and end-stage renal disease.
• Deposits typically affect kidneys, bone, skin, and vessels, but joint involvement can mimic other crystal arthropathies.

Purpose of the Study:

• To review the clinical, radiographic, and genetic aspects of oxalate crystal deposition disease.
• To discuss diagnostic approaches and current treatment strategies, including transplantation.
• To highlight the importance of understanding OCDD for managing other crystal deposition diseases.

Main Methods:

• Review of clinical presentations and radiographic findings of OCDD.
• Analysis of genetic defects in primary hyperoxalurias (PH1 and PH2).
• Evaluation of treatment outcomes, including kidney and combined liver-kidney transplantation.

Main Results:

• OCDD presents with musculoskeletal symptoms like osteopathy and arthropathy, often confused with other crystal diseases.
• Genetic studies enable precise early diagnosis of PH1 and PH2.
• Combined liver-kidney transplantation is the preferred treatment for PH1 with renal failure; isolated liver transplant is used for infantile cases.

Conclusions:

• Understanding the molecular basis of primary hyperoxalurias improves OCDD management and prevention.
• Early diagnosis through genetic testing is crucial.
• Transplantation strategies are evolving for effective treatment of severe OCDD.
• Insights into OCDD can inform the management of other calcium-containing crystal deposition diseases.